Literature DB >> 29709473

MiR-502 mediates esophageal cancer cell TE1 proliferation by promoting AKT phosphorylation.

Jing Xu1, Xiongxiong Pan2, Zhendong Hu3.   

Abstract

Esophageal cancer is one of the most common cancers in the world and esophageal squamous cell carcinoma is one of the two main types in esophageal cancer. MicroRNA is a small non-coding RNA molecule functions in many different cancers including esophageal cancer. We found miR-502 was up-regulated in esophageal tissues, which indicated miRNA-502 may play important roles in esophageal cancer. In this study, we used esophageal cancer cell line TE1 as an in vitro model for investigating the role of miR-502 in promoting the proliferation of the cancer cells. We found that overexpressing miR-502 in TE1 cells promoted the proliferation and inhibited the apoptosis induced by dox. Down-regulating miR-502 made the opposite phenomenon. Furthermore, western blot showed that miR-502 enhanced the phosphorylation levels of AKT pathways, which may be the mechanism of the overgrowth for esophageal cancer cell. Our data provide the evidence of a role for miR-502 in the regulation the proliferation of esophageal cancer cell through promoting the phosphorylation of AKT signaling. Due to its ability to promote the overgrowth of esophageal cancer cell, miR-502 may be a novel target for esophageal cancer therapeutic.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AKT; ERK; Esophageal cancer; MicroRNA; TE-1; miR-502

Mesh:

Substances:

Year:  2018        PMID: 29709473     DOI: 10.1016/j.bbrc.2018.04.188

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Mechanism of miR-204-5p in exosomes derived from bronchoalveolar lavage fluid on the progression of pulmonary fibrosis via AP1S2.

Authors:  Liang Zhu; Yahui Chen; Mo Chen; Wenwen Wang
Journal:  Ann Transl Med       Date:  2021-07

2.  Ultrasound-targeted microbubble destruction-mediated miR-767 inhibition suppresses tumor progression of non-small cell lung cancer.

Authors:  Xiaohua Li; Min Xu; Wenyu Lv; Xingwang Yang
Journal:  Exp Ther Med       Date:  2020-03-12       Impact factor: 2.447

Review 3.  Targeting Akt-associated microRNAs for cancer therapeutics.

Authors:  Mir S Adil; Daulat Khulood; Payaningal R Somanath
Journal:  Biochem Pharmacol       Date:  2020-12-24       Impact factor: 6.100

4.  Rab23 contributes to the progression of colorectal cancer via protein kinase B and extracellular signal-regulated kinase signaling pathways.

Authors:  Tongbi Zhao; Dong Han; Huan Meng
Journal:  Oncol Lett       Date:  2019-06-18       Impact factor: 2.967

5.  CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway.

Authors:  Zhongwei Zhao; Jingjing Song; Bufu Tang; Shiji Fang; Dengke Zhang; Liyun Zheng; Fazong Wu; Yang Gao; Chunmiao Chen; Xianghua Hu; Qiaoyou Weng; Yang Yang; Jianfei Tu; Jiansong Ji
Journal:  J Exp Clin Cancer Res       Date:  2020-11-25

6.  MicroRNA‑642a‑5p inhibits colon cancer cell migration and invasion by targeting collagen type I α1.

Authors:  Xiaoguang Wang; Zhengwei Song; Biwen Hu; Zhenwei Chen; Fei Chen; Chenxi Cao
Journal:  Oncol Rep       Date:  2020-12-18       Impact factor: 3.906

7.  Identification and validation of hub microRNAs dysregulated in esophageal squamous cell carcinoma.

Authors:  Chen Sang; Ce Chao; Min Wang; Youpu Zhang; Guanghua Luo; Xiaoying Zhang
Journal:  Aging (Albany NY)       Date:  2020-05-15       Impact factor: 5.682

Review 8.  Emerging Role of Non-Coding RNAs in Esophageal Squamous Cell Carcinoma.

Authors:  Qingqing Feng; Hongli Zhang; Denglin Yao; Wei-Dong Chen; Yan-Dong Wang
Journal:  Int J Mol Sci       Date:  2019-12-30       Impact factor: 5.923

9.  Time series expression pattern of key genes reveals the molecular process of esophageal cancer.

Authors:  Jiafu Wang; Xiang Xie; Yurong Sun
Journal:  Biosci Rep       Date:  2020-02-28       Impact factor: 3.840

10.  Angiotensin II enhances the proliferation of Natural Killer/T-cell lymphoma cells via activating PI3K/Akt signaling pathway.

Authors:  Gui-Hua Zhang; Fa-An Miao; Jin-Ge Xu; Yan Zhang
Journal:  Biosci Rep       Date:  2020-10-30       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.